A Randomized, Double ‐Blind, Parallel‐Group, Placebo‐Controlled, Multiple‐Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis

ConclusionsAMG 557 showed safety and potential efficacy, supporting further evaluation of the clinical efficacy of ICOSL blockade in patients with SLE.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - March 1, 2018 Category: Rheumatology Authors: Laurence E. Cheng, Zahir Amoura, Benjamin Cheah, Falk Hiepe, Barbara A. Sullivan, Lei Zhou, Gregory E. Arnold, Wayne H. Tsuji, Joan T. Merrill, James B. Chung Tags: Brief Report Source Type: research